Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

404

Not found

This newslink doesn't exist or it was removed.

Go to Homempage.

Sugerencias de la Hemeroteca

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

RTTNews USA Health March 15, 2023

thumbnailThe U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews

Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica


FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

RTTNews USA Health March 15, 2023

thumbnailThe U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews

Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica


BioNTech shares slip on gloomy Covid vaccine sales outlook

CNBC USA Health March 27, 2023

thumbnailVials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022.Rodrigo Garrido ReutersShares of on Monday slid by more than 6% in morning trading after the... + más

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews


In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over

The Boston Globe USA Business October 08, 2022

thumbnailPfizer and BioNTech, the duo behind the world’s most widely used COVID-19 vaccine, and one of the most successful pharmaceutical products of all time, are developing a trio of new vaccines that could spur stronger, broader, and longer-lasting immunity to the... + más

Moderna is suing Pfizer over its coronavirus vaccine | The Verge

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


Pfizer Seeks FDA Approval For Bivalent COVID-19 Vaccine In Kids Under 5

RTTNews USA Health December 06, 2022

thumbnailVaccine partners Pfizer Inc. and BioNTech SE are seeking emergency use authorization or EUA from the U.S. Food and Drug Administration to offer their bivalent COVID-19 vaccine to children 6 months through 4 years of age. If authorized, the vaccine would be part of a primary... + más

FDA greenlights bivalent vaccines for children as young as 6 months old | Politico

Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica



About iurex | Privacy Policy | Disclaimer |